Study of Cabozantinib Efficacy, Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients: CABOMAYOR Study
Clinical trial NCT04134390 · COMPLETED
Trial details
- NCT number
- NCT04134390
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-17
- Primary completion
- 2023-11-22
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.